Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 7, 2020
Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
Dennie Meijer, Maarten L Donswijk, Yves J L Bodar, et al.
BJU International
|
February 15, 2022
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
Yves J L Bodar, Hans Veerman, Dennie Meijer, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
September 13, 2024
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin
Heshu Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status
Idris Bahce, Egbert F Smit, Mark Lubberink, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2020
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H E Jansen, Matthijs C F Cysouw, André N Vis, et al.
European Journal of Clinical Pharmacology
|
June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 14, 2015
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer
Eline E Verwer, Daniela E Oprea-Lager, Alfons J M van den Eertwegh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 15, 2015
Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
Femke E Froklage, Andrey Postnov, Maqsood M Yaqub, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 31, 2020
<sup>11</sup>C-Sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for Early Evaluation of Sorafenib Therapy
Lemonitsa H Mammatas, Maqsood Yaqub, N Harry Hendrikse, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 7, 2020
Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
Dennie Meijer, Maarten L Donswijk, Yves J L Bodar, et al.
BJU International
|
February 15, 2022
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
Yves J L Bodar, Hans Veerman, Dennie Meijer, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
September 13, 2024
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin
Heshu Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status
Idris Bahce, Egbert F Smit, Mark Lubberink, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2020
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H E Jansen, Matthijs C F Cysouw, André N Vis, et al.
European Journal of Clinical Pharmacology
|
June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 14, 2015
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer
Eline E Verwer, Daniela E Oprea-Lager, Alfons J M van den Eertwegh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 15, 2015
Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
Femke E Froklage, Andrey Postnov, Maqsood M Yaqub, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 31, 2020
<sup>11</sup>C-Sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for Early Evaluation of Sorafenib Therapy
Lemonitsa H Mammatas, Maqsood Yaqub, N Harry Hendrikse, et al.
Page
of 10